MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cimb48090866

Медицинская библиотека · Current issues in molecular biology · 2026

Comparative Evaluation of Traditional and Emerging Glycemic Biomarkers in Diabetes.

Jones Jeremy, Frenia Kyla, Garwood Kathleen C, Xiao Kunhong, Labriola Leanne T

СтатьяОбзорПеревод в очереди

Аннотация

Diabetes mellitus is a worldwide metabolic disorder that can be debilitating to many if uncontrolled. Biomarkers, such as hemoglobin A1C and glycated albumin, are central to the effort to control diabetes. These each have their own advantages and disadvantages, and there is much ongoing research into development of improved biomarkers and biomarker measurement methods. Continuous glucose monitoring is also widely used to closely monitor diabetes in patients today. Increasingly, however, there has been research focusing on the use of biomarkers in alternative mediums, such as tear fluid or saliva. This review efficiently summarizes the current biomarkers used clinically today, their advantages and disadvantages, and the biomarkers on the horizon that could advance how diabetes is treated in the future.

Для цитирования: Jones Jeremy, Frenia Kyla, Garwood Kathleen C, Xiao Kunhong, Labriola Leanne T. Comparative Evaluation of Traditional and Emerging Glycemic Biomarkers in Diabetes.. Current issues in molecular biology. 2026. DOI: 10.3390/cimb48090866.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.